Brief: Meridian Bioscience Reports Q4 results

VivoPower

22/11/2022 13:06

Nov 22 (Reuters) - Meridian Bioscience Inc  VIVO.O :
    * MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR
FISCAL
2022 OPERATING RESULTS
    * MERIDIAN BIOSCIENCE INC Q4 REVENUE ROSE 5 PERCENT TO
$333.0
MILLION
    * MERIDIAN BIOSCIENCE INC - QTRLY DILUTED EPS OF $0.13
    * MERIDIAN BIOSCIENCE INC - QTRLY ADJUSTED DILUTED EPS OF
$0.20

Source text for Eikon:  ID:nPn5NHxska 
Further company coverage:  VIVO.O 
 ((Reuters.Briefs@thomsonreuters.com;))